{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T03:01:27Z","timestamp":1790305287375,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"French Ministry of Health","award":["Inter-regional Hospital Clinical Research Program 2019"],"award-info":[{"award-number":["Inter-regional Hospital Clinical Research Program 2019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fluid overload is associated with worse outcome in critically ill patients requiring continuous renal replacement therapy (CRRT). Net ultrafiltration (UF<jats:sub>NET<\/jats:sub>) allows precise control of the fluid removal but is frequently ceased due to hemodynamic instability episodes. However, approximately 50% of the hemodynamic instability episodes in ICU patients treated with CRRT are not associated with preload dependence (i.e., are not related to a decrease in cardiac preload), suggesting that volume removal is not responsible for these episodes of hemodynamic impairment. The use of advanced hemodynamic monitoring, comprising continuous cardiac output monitoring to repeatedly assess preload dependency, could allow securing UF<jats:sub>NET<\/jats:sub> to allow fluid balance control and prevent fluid overload.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The GO NEUTRAL trial is a multicenter, open-labeled, randomized, controlled, superiority trial with parallel groups and balanced randomization with a 1:1 ratio. The trial will enroll adult patients with acute circulatory failure treated with vasopressors and severe acute kidney injury requiring CRRT who already have been equipped with a continuous cardiac output monitoring device. After informed consent, patients will be randomized into two groups. The control group will receive protocolized fluid removal with an UF<jats:sub>NET<\/jats:sub> rate set to 0\u201325 ml h<jats:sup>\u22121<\/jats:sup> between inclusion and H72 of inclusion. The intervention group will be treated with an UF<jats:sub>NET<\/jats:sub> rate set on the CRRT of at least 100 ml h<jats:sup>\u22121<\/jats:sup> between inclusion and H72 of inclusion if hemodynamically tolerated based on a protocolized hemodynamic protocol aiming to adjust UF<jats:sub>NET<\/jats:sub> based on cardiac output, arterial lactate concentration, and preload dependence assessment by postural maneuvers, performed regularly during nursing rounds, and in case of a hemodynamic instability episode. The primary outcome of the study will be the cumulative fluid balance between inclusion and H72 of inclusion. Randomization will be generated using random block sizes and stratified based on fluid overload status at inclusion. The main outcome will be analyzed in the modified intention-to-treat population, defined as all alive patients at H72 of inclusion, based on their initial allocation group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>We present in the present protocol all study procedures in regard to the achievement of the GO NEUTRAL trial, to prevent biased analysis of trial outcomes and improve the transparency of the trial result report. Enrollment of patients in the GO NEUTRAL trial has started on June 31, 2021, and is ongoing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov NCT04801784. Registered on March 12, 2021, before the start of inclusion.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06735-6","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T07:03:26Z","timestamp":1663830206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Fluid balance neutralization secured by hemodynamic monitoring versus protocolized standard of care in critically ill patients requiring continuous renal replacement therapy: study protocol of the GO NEUTRAL randomized controlled trial"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4698-053X","authenticated-orcid":false,"given":"Laurent","family":"Bitker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Pradat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kada","family":"Klouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Illinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Souweine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"issue":"1","key":"6735_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12882-016-0323-6","volume":"17","author":"R Claure-Del Granado","year":"2016","unstructured":"Claure-Del Granado R, Mehta RL. Fluid overload in the ICU: evaluation and management. BMC Nephrol. 2016;17(1):109.","journal-title":"BMC Nephrol"},{"issue":"5","key":"6735_CR2","doi-asserted-by":"publisher","first-page":"R197","DOI":"10.1186\/cc11682","volume":"16","author":"ST Vaara","year":"2012","unstructured":"Vaara ST, Korhonen AM, Kaukonen KM, Nisula S, Inkinen O, Hoppu S, et al. Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study. Crit Care. 2012;16(5):R197.","journal-title":"Crit Care"},{"key":"6735_CR3","doi-asserted-by":"crossref","unstructured":"Sakr Y, Rubatto Birri PN, Kotfis K, Nanchal R, Shah B, Kluge S, et al. Higher fluid balance increases the risk of death from sepsis: results from a large international audit. Crit Care Med. 2016;45(3):386-94.","DOI":"10.1097\/CCM.0000000000002189"},{"issue":"11","key":"6735_CR4","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00134-016-4500-7","volume":"42","author":"PB Hjortrup","year":"2016","unstructured":"Hjortrup PB, Haase N, Bundgaard H, Thomsen SL, Winding R, Pettila V, et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016;42(11):1695\u2013705.","journal-title":"Intensive Care Med"},{"issue":"24","key":"6735_CR5","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1056\/NEJMoa062200","volume":"354","author":"HP Wiedemann","year":"2006","unstructured":"National Heart Lung Blood Institute, Acute Respiratory Distress Syndrome Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564\u201375.","journal-title":"N Engl J Med"},{"issue":"1","key":"6735_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"KDIGO clinical practice guideline for acute kidney injury","year":"2012","unstructured":"KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1\u2013138.","journal-title":"Kidney Int Suppl"},{"issue":"8","key":"6735_CR7","doi-asserted-by":"publisher","first-page":"e749","DOI":"10.1097\/CCM.0000000000002372","volume":"45","author":"V Balakumar","year":"2017","unstructured":"Balakumar V, Murugan R, Sileanu FE, Palevsky P, Clermont G, Kellum JA. Both positive and negative fluid balance may be associated with reduced long-term survival in the critically ill. Crit Care Med. 2017;45(8):e749\u2013e57.","journal-title":"Crit Care Med"},{"issue":"12","key":"6735_CR8","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.2215\/CJN.04470709","volume":"4","author":"JO Burton","year":"2009","unstructured":"Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol. 2009;4(12):1925\u201331.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"6735_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13613-021-00883-9","volume":"11","author":"G Chazot","year":"2021","unstructured":"Chazot G, Bitker L, Mezidi M, Chebib N, Chabert P, Chauvelot L, et al. Prevalence and risk factors of hemodynamic instability associated with preload-dependence during continuous renal replacement therapy in a prospective observational cohort of critically ill patients. Ann Intensive Care. 2021;11(1):95.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"6735_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13613-016-0149-1","volume":"6","author":"X Monnet","year":"2016","unstructured":"Monnet X, Cipriani F, Camous L, Sentenac P, Dres M, Krastinova E, et al. The passive leg raising test to guide fluid removal in critically ill patients. Ann Intensive Care. 2016;6(1):46.","journal-title":"Ann Intensive Care"},{"issue":"10","key":"6735_CR11","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1097\/CCM.0000000000003276","volume":"46","author":"JA Silversides","year":"2018","unstructured":"Silversides JA, Fitzgerald E, Manickavasagam US, Lapinsky SE, Nisenbaum R, Hemmings N, et al. Deresuscitation of patients with iatrogenic fluid overload is associated with reduced mortality in critical illness. Crit Care Med. 2018;46(10):1600\u20137.","journal-title":"Crit Care Med"},{"issue":"6","key":"6735_CR12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s13054-014-0624-8","volume":"18","author":"JA Silversides","year":"2014","unstructured":"Silversides JA, Pinto R, Kuint R, Wald R, Hladunewich MA, Lapinsky SE, et al. Fluid balance, intradialytic hypotension, and outcomes in critically ill patients undergoing renal replacement therapy: a cohort study. Crit Care. 2014;18(6):624.","journal-title":"Crit Care"},{"issue":"4","key":"6735_CR13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/ki.2009.159","volume":"76","author":"J Bouchard","year":"2009","unstructured":"Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76(4):422\u20137.","journal-title":"Kidney Int"},{"issue":"1","key":"6735_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13054-018-2163-1","volume":"22","author":"R Murugan","year":"2018","unstructured":"Murugan R, Balakumar V, Kerti SJ, Priyanka P, Chang CH, Clermont G, et al. Net ultrafiltration intensity and mortality in critically ill patients with fluid overload. Crit Care. 2018;22(1):223.","journal-title":"Crit Care"},{"issue":"6","key":"6735_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.5418","volume":"2","author":"R Murugan","year":"2019","unstructured":"Murugan R, Kerti SJ, Chang CH, Gallagher M, Clermont G, Palevsky PM, et al. Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: a secondary analysis of the randomized evaluation of normal vs augmented level (RENAL) of renal replacement therapy trial. JAMA Netw Open. 2019;2(6):e195418.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"6735_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/MCC.0000000000000090","volume":"20","author":"MR Pinsky","year":"2014","unstructured":"Pinsky MR. Functional haemodynamic monitoring. Curr Opin Crit Care. 2014;20(3):288\u201393.","journal-title":"Curr Opin Crit Care"},{"issue":"7","key":"6735_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707\u201310.","journal-title":"Intensive Care Med"},{"issue":"15","key":"6735_CR18","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1056\/NEJMoa1803213","volume":"379","author":"SD Barbar","year":"2018","unstructured":"Barbar SD, Clere-Jehl R, Bourredjem A, Hernu R, Montini F, Bruyere R, et al. Timing of renal-replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med. 2018;379(15):1431\u201342.","journal-title":"N Engl J Med"},{"issue":"1","key":"6735_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13613-015-0093-5","volume":"5","author":"C Vinsonneau","year":"2015","unstructured":"Vinsonneau C, Allain-Launay E, Blayau C, Darmon M, Ducheyron D, Gaillot T, et al. Renal replacement therapy in adult and pediatric intensive care: recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care Emergencies (GFRUP) the French Dialysis Society (SFD). Ann Intensive Care. 2015;5(1):58.","journal-title":"Ann Intensive Care"},{"issue":"5","key":"6735_CR20","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1097\/01.CCM.0000215453.11735.06","volume":"34","author":"X Monnet","year":"2006","unstructured":"Monnet X, Rienzo M, Osman D, Anguel N, Richard C, Pinsky MR, et al. Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med. 2006;34(5):1402\u20137.","journal-title":"Crit Care Med"},{"key":"6735_CR21","doi-asserted-by":"crossref","unstructured":"Yonis H, Bitker L, Aublanc M, Perinel Ragey S, Riad Z, Lissonde F, et al. Change in cardiac output during Trendelenburg maneuver is a reliable predictor of fluid responsiveness in patients with acute respiratory distress syndrome in the prone position under protective ventilation. Crit Care. 2017;21(1):295.","DOI":"10.1186\/s13054-017-1881-0"},{"key":"6735_CR22","doi-asserted-by":"crossref","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304-77.","DOI":"10.1007\/s00134-017-4683-6"},{"issue":"6","key":"6735_CR23","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s13546-014-0917-6","volume":"23","author":"L Van Vong","year":"2014","unstructured":"Van Vong L, Osman D, Vinsonneau C. \u00c9puration extrar\u00e9nale en r\u00e9animation adulte et p\u00e9diatrique. Recommandations formalis\u00e9es d\u2019experts sous l\u2019\u00e9gide de la Soci\u00e9t\u00e9 de r\u00e9animation de langue fran\u00e7aise (SRLF), avec la participation de la Soci\u00e9t\u00e9 fran\u00e7aise d\u2019anesth\u00e9sie-r\u00e9animation (Sfar), du Groupe francophone de r\u00e9animation et urgences p\u00e9diatriques (GFRUP) et de la Soci\u00e9t\u00e9 francophone de dialyse (SFD). R\u00e9animation. 2014;23(6):714\u201337.","journal-title":"R\u00e9animation."},{"key":"6735_CR24","doi-asserted-by":"crossref","unstructured":"Yehya N, Harhay MO, Curley MAQ, Schoenfeld DA, Reeder RW. Re-appraisal of ventilator-free days in critical care research. Am J Respir Crit Care Med. 2019;200(7):828-36.","DOI":"10.1164\/rccm.201810-2050CP"},{"issue":"23","key":"6735_CR25","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","volume":"372","author":"J-P Frat","year":"2015","unstructured":"Frat J-P, Thille AW, Mercat A, Girault C, Ragot S, Perbet S, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(23):2185\u201396.","journal-title":"N Engl J Med"},{"issue":"9","key":"6735_CR26","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/ndt\/gfp159","volume":"24","author":"SM Bagshaw","year":"2009","unstructured":"Bagshaw SM, Uchino S, Cruz D, Bellomo R, Morimatsu H, Morgera S, et al. A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury. Nephrol Dial Transplant. 2009;24(9):2739\u201344.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"6735_CR27","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/ki.2012.451","volume":"83","author":"Z Harel","year":"2013","unstructured":"Harel Z, Wald R, Bargman JM, Mamdani M, Etchells E, Garg AX, et al. Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors. Kidney Int. 2013;83(5):901\u20138.","journal-title":"Kidney Int"},{"issue":"8","key":"6735_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA."},{"key":"6735_CR29","volume-title":"Common terminology criteria for adverse events : (CTCAE)","author":"National Cancer Institute","year":"2010","unstructured":"National Cancer Institute. Common terminology criteria for adverse events : (CTCAE). 2010."},{"issue":"1","key":"6735_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/0976500X20100101","volume":"1","author":"International Committee of Medical Journal Editors (ICMJE)","year":"2010","unstructured":"International Committee of Medical Journal Editors (ICMJE). Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. J Pharmacol Pharmacother. 2010;1(1):42\u201358.","journal-title":"J Pharmacol Pharmacother"},{"key":"6735_CR31","doi-asserted-by":"crossref","unstructured":"Bitker L, Bayle F, Yonis H, Gobert F, Leray V, Taponnier R, et al. Prevalence and risk factors of hypotension associated with preload-dependence during intermittent hemodialysis in critically ill patients. Crit Care. 2016;20(1):44.","DOI":"10.1186\/s13054-016-1227-3"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06735-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06735-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06735-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T13:41:55Z","timestamp":1664977315000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06735-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6735"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06735-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,22]]},"assertion":[{"value":"26 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The GO NEUTRAL study (protocol version 1) was approved by a human research ethics committee (Comit\u00e9 de Protection des Personnes Sud-M\u00e9diterran\u00e9e I) on April 29, 2021, under the reference number IDRCB 2021-A00692-39 (Supplemental Material  for the French and English versions). The trial received authorization to start from the French regulatory agency (Agence National de S\u00e9curit\u00e9 du M\u00e9dicament) on May 27, 2021.Written informed consent will be obtained from all participants and\/or their legal representative if the participant is in a medical condition that does not allow informed consent. A model consent form will be provided upon request to the corresponding author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0{24}"}},{"value":"Not applicable. No clinical details of trial participants are presented in the present article or will be presented in reports of the trial results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication\u00a0{32}"}},{"value":"The authors declare they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests\u00a0{28}"}}],"article-number":"798"}}